It is interesting to note that schaftoside significantly upregulated the expression of filaggrin, thereby suggesting that schaftoside could be a useful natural bioactive component in the future treatment of some of the most common dermatological diseases, such as atopic dermatitis and psoriasis. Here, FLG is linked to atopic eczema.